Itoh Saotomo, Takeshita Kana, Susuki Chie, Shige-Eda Kazunori, Tsuji Tsutomu
Department of Microbiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.
Biomaterials. 2008 Jul;29(21):3084-90. doi: 10.1016/j.biomaterials.2008.04.018. Epub 2008 May 2.
The formation of platelet-neutrophil microaggregates and successive activation of neutrophils are closely related to hemodialysis-associated complications. The microaggregate is mediated primarily by the interaction between P-selectin (CD62P) expressed on activated platelets and P-selectin glycoprotein ligand-1 (PSGL-1, CD162) expressed on neutrophils. We previously reported that the clustered distribution of PSGL-1 on the cell membranes of chemokine-treated neutrophils caused upregulation of the microaggregate formation. In this study, we found that neutrophils treated with human plasma that had been incubated with hemodialysis membranes greatly enhanced the microaggregate formation. The membrane-treated plasma also induced PSGL-1 to form a cap-like cluster on the neutrophil surface. Analysis of several hemodialysis membranes with different materials indicated that the inducibility for the cap-like cluster formation of PSGL-1 parallels their ability to activate the complement system. Both the enhancement of microaggregate formation and the redistribution of PSGL-1 induced by the hemodialysis membrane-treated plasma were almost completely abrogated in the presence of a specific antagonist for the complement component C5a receptor, W-54011. These results strongly suggest that the generation of anaphylatoxin C5a through complement activation induced by hemodialysis membranes is responsible for the clustered redistribution of PSGL-1 in neutrophils leading to the increase in the platelet-neutrophil microaggregate formation. The present study indicates the importance of synergistic exacerbation of complement activation and platelet-neutrophil microaggregate formation in developing hemodialysis-associated complications.
血小板-中性粒细胞微聚集体的形成以及中性粒细胞的相继激活与血液透析相关并发症密切相关。微聚集体主要由活化血小板上表达的P-选择素(CD62P)与中性粒细胞上表达的P-选择素糖蛋白配体-1(PSGL-1,CD162)之间的相互作用介导。我们之前报道过,趋化因子处理的中性粒细胞细胞膜上PSGL-1的簇状分布导致微聚集体形成上调。在本研究中,我们发现用与血液透析膜孵育过的人血浆处理的中性粒细胞极大地增强了微聚集体的形成。经膜处理的血浆还诱导PSGL-1在中性粒细胞表面形成帽状簇。对几种不同材料的血液透析膜进行分析表明,PSGL-1形成帽状簇的诱导能力与其激活补体系统的能力平行。在存在补体成分C5a受体特异性拮抗剂W-54011的情况下,血液透析膜处理的血浆诱导的微聚集体形成增强和PSGL-1的重新分布几乎完全被消除。这些结果强烈表明,血液透析膜诱导补体激活产生的过敏毒素C5a是导致中性粒细胞中PSGL-1簇状重新分布从而导致血小板-中性粒细胞微聚集体形成增加的原因。本研究表明在发生血液透析相关并发症时补体激活与血小板-中性粒细胞微聚集体形成协同加重的重要性。